Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (opens in a new tab)
CompletedPhase 2
Atezolizumab
Dr. Connie D. Uzel, MD
NPI1982657755PAC ID1052213923
- Medicare services, 2024
- 27,123
- Medicare patients, 2024
- 391
- Part D claims, 2024
- 1,931
- Clinical trials
- 10
- MIPS score, 2024
- 92
- Practice address
- 29653 Anchor Cross Blvd, Daphne, AL 36526
- Practice phone
- Call (251) 625-6896
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Southern Cancer Center
Daphne, Alabama
Find Dr. Uzel's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Connie D. Uzel is a hematologist and oncologist in Daphne, Alabama
Dr. Uzel practices at Southern Cancer Center in Daphne, Alabama.
Dr. Uzel's NPI, 1982657755, was assigned on May 19, 2006. Dr. Uzel graduated from University of Arkansas College of Medicine in 1988. Dr. Uzel holds Alabama license 14756.
NPI and contact details
- NPI
- 1982657755NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1052213923
- NPI enumeration date
- May 19, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (251) 625-6896
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 64
- Medical school graduation
- 1988
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Connie D. Uzel practices at Southern Cancer Center in Daphne, Alabama
Dr. Uzel's primary practice is Southern Cancer Center, at 29653 Anchor Cross Blvd, Daphne, AL 36526 in Baldwin County. The practice phone is (251) 625-6896.
- Southern Cancer Center29653 Anchor Cross Blvd, Daphne, AL 36526 · Baldwin CountyPhone(251) 625-6896
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Connie D. Uzel is affiliated with 4 sites of care and 1 medical group
Dr. Uzel's primary practice is Southern Cancer Center in Daphne, Alabama. Dr. Uzel is also affiliated with Mobile Infirmary. The medical group on file is Southern Cancer Center. Dmand AI also links Dr. Uzel to 2 more hospitals, each named with a free account.
Southern Cancer CenterPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Connie D. Uzel's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Uzel practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Southern Cancer Center | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Uzel practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Connie D. Uzel is one of 169 hematologists and oncologists in Alabama
Hematology and oncology is Dr. Uzel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Uzel is licensed in Alabama.
Specialties and state licenses
- Hematology and oncology, AlabamaPrimary
Hematologists and oncologists near Dr. Uzel
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
169hematologists and oncologists in Alabama
7hematologists and oncologists in Daphne
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Connie D. Uzel billed Medicare for 27,123 services in 2024
CMS data shows 27,123 Medicare services from Dr. Uzel across 37 procedure codes in 2024, for 391 Medicare patients. Medicare paid $628,987 for them.
Medicare services, 202427,123
Medicare patients391
Paid by Medicare$628,987
Procedure codes37
Dr. Uzel's Medicare services by type, 2024
- Drugs given in the office22,274
- Lab and pathology1,643
- Tests and treatments922
- Other services906
- Office and hospital visits847
- Surgery531
Where Dr. Uzel's Medicare services took place, 2024
- In an office26,93099%
- In a facility1931%
Dr. Uzel compared with the Alabama median for hematologists and oncologists, 2024
- Dr. Uzel
- Alabama median
- Medicare services
- 27,123vs 1,22422.2 times
- Medicare patients
- 391vs 28239% above
- Part D claims
- 1,609vs 84690% above
Medians across 162 hematologists and oncologists in Alabama with Dmand AI profiles that report each measure.
Dr. Uzel's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Uzel?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Uzel and other hematologists and oncologists in Alabama.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Connie D. Uzel treated 391 Medicare patients in 2024, average age 75
CMS counts 391 Medicare patients who saw Dr. Uzel in 2024. The largest group is 65 to 74, with 160 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Uzel's median patient age at 70, with 63% women.
Medicare patients, 2024391
Average age75
Average risk score2.13
Also on Medicaid9%
Dr. Uzel's Medicare patients by age, 2024
Dr. Uzel's Medicare patients by sex, 2024
- Women22157%
- Men17043%
Chronic conditions among Dr. Uzel's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Ischemic heart disease49%
- Cancer48%
- Chronic kidney disease46%
- Arthritis45%
- Diabetes40%
- Heart failure31%
Share of Medicare patients with each condition. A patient can have several.
Dr. Uzel's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women63%
- Men37%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Connie D. Uzel wrote 1,931 Medicare Part D claims in 2024
In 2024, Dr. Uzel wrote 1,931 Medicare Part D claims for 274 patients. 74% of them were for generic drugs. CMS names the drug for 1,609 of them, across 44 drugs with 11 or more claims each, at $6,327,798 in total drug cost.
Part D claims, 20241,931
Drugs named by CMS44
Total drug cost$6.3M
Part D patients274
Dr. Uzel's Part D claims by kind of drug, 2024
- Generic1,427 claims74%
- Brand-name and other504 claims26%
Dr. Uzel's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Uzel's Part D claims, 2024
- Opioids3%57 of 1,931 claims
- Antibiotics2%45 of 1,931 claims
- Antipsychotics, patients 65 and over1%27 of 1,931 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Connie D. Uzel scored 92 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Uzel for performance year 2024. Dr. Uzel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Uzel's MIPS scores, performance year 2024
- 92of 100Final score
- 91.9of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 72of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Uzel by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Connie D. Uzel has worked on 10 clinical trials
Dmand AI links Dr. Uzel to 10 clinical trials, 6 of them phase 3 studies. 7 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Breast Neoplasms. National Cancer Institute (NCI) sponsors the most, 6.
Clinical trials with Dr. Uzel by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 1Phase 2/3: 1 trial
- 6Phase 3: 6 trials
- NonePhase 4: no trials
Conditions in Dr. Uzel's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Breast Neoplasms
- Rectal Neoplasms
- Breast Diseases
Investigators on the most trials with Dr. Uzel
- Beverly J. Drucker, MD6 shared trials
- James Mitchell Granfortuna, MD6 shared trials
- James M. Grichnik, MD6 shared trials
Recent clinical trials with Dr. Uzel
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer (opens in a new tab)
Active, not recruitingPhase 3
Breast Carcinoma In SituCarcinoma in SituPembrolizumabRadiation Therapy
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer (opens in a new tab)
CompletedPhase 2
Rectal NeoplasmsRectal DiseasesPembrolizumabVeliparibCapecitabine
Breast Cancer WEight Loss Study (BWEL Study) (opens in a new tab)
Active, not recruitingPhase 3
Breast NeoplasmsBreast Diseases
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Connie D. Uzel received $2,400 in industry payments from 2024 to 2025
CMS Open Payments shows 122 general payments to Dr. Uzel from 33 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 99% of the total. Novartis Pharmaceuticals Corporation paid the most, $304.
General payments to Dr. Uzel by program year, 2024 to 2025
General payments to Dr. Uzel by kind, 2024 to 2025
$2.4Kin total
- Food and beverage$2,38399%
- Education$171%
Companies that paid Dr. Uzel the most, 2024 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Connie D. Uzel graduated from University of Arkansas College of Medicine
Dr. Uzel graduated from University of Arkansas College of Medicine in 1988.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Connie D. Uzel's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Connie D. Uzel
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Connie D. Uzel's NPI number?
Dr. Connie D. Uzel's NPI number is 1982657755. It was assigned on May 19, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Connie D. Uzel?
Dr. Connie D. Uzel is a hematologist and oncologist in Daphne, Alabama. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Connie D. Uzel practice?
Dr. Uzel practices at 29653 Anchor Cross Blvd, Daphne, AL 36526. Dr. Uzel's primary practice is Southern Cancer Center in Daphne, Alabama. Dmand AI also links Dr. Uzel to 2 hospitals.
What is Dr. Connie D. Uzel's office phone number?
The practice phone on file for Dr. Uzel is (251) 625-6896.
What is Dr. Connie D. Uzel's medical license number?
Dr. Uzel holds Alabama license 14756.
Which hospitals is Dr. Connie D. Uzel affiliated with?
Dr. Uzel is affiliated with Mobile Infirmary. Dmand AI links Dr. Uzel to 2 more hospitals.
What medical group is Dr. Connie D. Uzel part of?
Dr. Uzel is linked to Southern Cancer Center.
Does Dr. Connie D. Uzel accept Medicare?
Yes. CMS data shows Dr. Uzel billed Medicare for 27,123 services in 2024, and Dr. Uzel accepts Medicare assignment.
What is Dr. Connie D. Uzel's MIPS score?
Dr. Uzel's MIPS final score for performance year 2024 is 92 out of 100.
How many Medicare patients does Dr. Connie D. Uzel see?
CMS counts 391 Medicare patients who saw Dr. Uzel in 2024, with an average age of 75.
Show 6 more questionsShow fewer questions
What services does Dr. Connie D. Uzel bill to Medicare?
In 2024, Dr. Uzel's most billed Medicare services were injected or infused drug (J9271), injected or infused drug (J1453) and injected or infused drug (J0897).
Where did Dr. Connie D. Uzel go to medical school?
Dr. Uzel graduated from University of Arkansas College of Medicine in 1988.
What drugs does Dr. Connie D. Uzel prescribe most?
In 2024 Medicare Part D data, Dr. Uzel's most prescribed drugs by claims were Letrozole, Exemestane and Ondansetron HCl.
Has Dr. Connie D. Uzel received payments from drug or device companies?
CMS Open Payments shows $2,400 in general payments to Dr. Uzel from 33 companies from 2024 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Connie D. Uzel been practicing?
Dr. Uzel graduated from medical school in 1988, 38 years ago.
Does Dr. Connie D. Uzel do research?
Dr. Uzel has worked on 10 clinical trials.
Selling to hematology and oncology practices?
See hematologists and oncologists in Alabama by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card